This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.Find sources: "MEDA" – news · newspapers · books · scholar · JSTOR (July 2019)

MEDA
Names

Preferred IUPAC name 1-(8-Methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
Identifiers
CAS Number	23693-25-6^Y
3D model (JSmol)	Interactive image
ChemSpider	24034^Y
KEGG	D03376^Y
PubChem CID	25798
UNII	T2DAA4TB22^Y
InChI InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3^N Key: NRVFDGZJTPCULU-UHFFFAOYSA-N^Y InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 Key: HEYPARQBPGSFKW-UHFFFAOYSA-N
SMILES NC(CC1=CC2=C(OCCO2)C(OC)=C1)C
Properties
Chemical formula	C₁₂H₁₇NO₃
Molar mass	223.272 g·mol⁻¹
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is ^YN ?) Infobox references

MEDA (3-methoxy-4,5-ethylenedioxyamphetamine) is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown.^[1] MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.

See also

References